MacroGenics (MGNX)
(Delayed Data from NSDQ)
$14.67 USD
+0.01 (0.07%)
Updated May 9, 2024 04:00 PM ET
After-Market: $5.25 -9.42 (-64.21%) 6:24 PM ET
4-Sell of 5 4
F Value D Growth C Momentum F VGM
Brokerage Reports
0 items in cart
MacroGenics, Inc. [MGNX]
Reports for Purchase
Showing records 121 - 140 ( 360 total )
Company: MacroGenics, Inc.
Industry: Medical - Products
Company: MacroGenics, Inc.
Industry: Medical - Products
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: MacroGenics, Inc.
Industry: Medical - Products
Company: MacroGenics, Inc.
Industry: Medical - Products
Company: MacroGenics, Inc.
Industry: Medical - Products
Company: MacroGenics, Inc.
Industry: Medical - Products
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: MacroGenics, Inc.
Industry: Medical - Products
2H19 Updates From Multiple Programs as Key Sentiment Drivers
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: MacroGenics, Inc.
Industry: Medical - Products
Company: MacroGenics, Inc.
Industry: Medical - Products
Looking to Marry Off Marge as BLA Filing Nears
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: MacroGenics, Inc.
Industry: Medical - Products
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: MacroGenics, Inc.
Industry: Medical - Products
Company: MacroGenics, Inc.
Industry: Medical - Products
Servier Flotetuzumab Discontinuation Has Minimal Impact Read Through to Story
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: MacroGenics, Inc.
Industry: Medical - Products
Company: MacroGenics, Inc.
Industry: Medical - Products
Biotechnology - ASCO Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: MacroGenics, Inc.
Industry: Medical - Products
SOPHIA Update Inline with Expectations, Path Forward in Gastric
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: MacroGenics, Inc.
Industry: Medical - Products
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: MacroGenics, Inc.
Industry: Medical - Products
The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Company: MacroGenics, Inc.
Industry: Medical - Products
Biotechnology- ASCO Abstract Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Company: MacroGenics, Inc.
Industry: Medical - Products
ASCO Abstract Should Eliminate Concerns on Approvability
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHATTOPADHYAY D
Company: MacroGenics, Inc.
Industry: Medical - Products
SOPHIA ASCO Abstract Shows PFS Benefit, Trend to OS
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D